In the annual “Taiwan BIO Awards”, SunWay Biotech passed all the steps from the preliminary review to the final one by its multinational patents and strain-based market planning. SunWay Biotech has stood out from 55 biotechnology industry companies and awarded “Taiwan BIO Awards- Emerging Company of the Year“ in 2020!   BIO Asia-Taiwan 2020 International Conference & Exhibition SunWay Biotech company is awarded by President Tsai, Ing-Wen Professor Pan, Tzu-Ming introduced the history of SunWay Biotech company Speech of Professor Pan, Tzu-Ming Professor Pan, Tzu-Ming SunWay Biotech is awarded “Taiwan Bio Awards” in 2020.

  We are honored to be awarded the Gold Award of 2022 Taiwan BIO Award! After three months of evaluation, the Taiwan Bio Industry Organization (TBIO) has selected 14 companies as the 2022 winners of the Taiwan BIO Awards by evaluating their operational performance, development potential, research and development capabilities, and social contribution. SunWay Biotech is honored to be listed as one of the winners awarded the Gold Award of 2022 Taiwan BIO Award! “SunWay Biotech Co., LTD.” was founded in 2007. As a leading world-class dietary supplement expert, SunWay Biotech aims to apply diverse and effective microorganisms, and develop efficient and unique fermentation processes, to provide high-quality products that ensure carefree health across the globe. “We hope to become the Intel in the dietary supplement industry, as the CPU of Intel which can be the core of the different computer brands. Our original, functional branded ingredients will play a vital role like the heart in the global dietary supplement company,” said John Pan, President of SunWay Biotech. Meanwhile, SunWay has performed many clinical trials, including regulating blood lipids, blood sugar, blood pressure, and Alzheimer’s disease, to demonstrate the benefits of our patented ingredients- ANKASCIN 568-R in Taiwan, Tientsin, and Los Angeles. Moreover, we also have two clinical trials in progress related to blood lipids regulation (HDL-C) and blood sugar modulation […]

Keep up with the latest trend! Everyone should pay more attention to the side effect of Monacolin K (lovastatin). EU’s new red yeast rice supplements regulation has changed and is now effective — Individual portion of the product for daily consumption shall provide less than 3mg of monacolins from red yeast rice product, and manufacturers should clearly indicate the information like the daily amount of monacolins, and warnings in combination with cholesterol-lowering medication. Get the details of the article of European Commission regulation. https://rb.gy/vo8ggk The level of monacolin k in red yeast rice supplements in European countries has changed from various levels to less than 3mg for daily consumption. This is because some people taking both statin drugs and supplements to help manage hyperlipidemia might experience side effects due to overdose, thereby causing muscle weakness, pain, or rhabdomyolysis. ANKASCIN 568-R, the only red yeast rice that is without Monacolin K, but with better benefits for heart health backed by clinical trials. Contact us to know more!